Open AccessModern medical technologies in pediatric oncology: organ-preserving treatment for malignant solid tumors
Author(s) -
L. A. Durnov,
G V Goldobenko,
T. A. Sharoev,
V. G. Polyakov,
N. M. Ivanova,
А. П. Казанцев
Publication year - 2022
Publication title -
kazanskij medicinskij žurnal
Language(s) - English
Resource type - Journals
eISSN - 2587-9359
pISSN - 0368-4814
DOI - 10.17816/kazmj99777
Subject(s) - retinoblastoma , medicine , pediatric oncology , surprise , wilms' tumor , oncology , pediatrics , cancer , psychology , social psychology , biochemistry , chemistry , gene
The successes achieved by pediatric oncologists represent the realization of the scientific and technological progress of modern times. The results of treatment of nephroblastoma, retinoblastoma, and bone sarcomas look especially demonstratively. The fact that at least 95% of children recover in the treatment of localized forms of nephroblastoma and retinoblastoma, and more than 50% of patients with bone sarcomas is considered commonplace and does not surprise pediatric oncologists. Unfortunately, the price of such results of therapy is often too high. A child whom we consider to have recovered from a malignant tumor, in fact, remains disabled since childhood due to the loss of a kidney or vision, or a limb.